Bradley Patt
Chief Executive Officer at Theracell, Inc.
Profile
Bradley E.
Patt is the founder of four companies.
He founded Theracell, Inc. in 2008 and is currently the Chief Executive Officer.
He founded Gamma Medica-Ideas (USA), Inc. in 2000 and was the President & Chief Executive Officer until 2013.
He founded HyVIDA Brands, Inc. in 2013 and is currently the Chairman.
He founded Tetrous, Inc. in 2019 and is currently the Chairman & Chief Executive Officer.
Dr. Patt's former job was as the Head-Research & Product Development at Advanced Detectors, Inc.
Bradley Patt active positions
Companies | Position | Start |
---|---|---|
Theracell, Inc.
Theracell, Inc. Medical SpecialtiesHealth Technology Part of Isto Biologics (Massachusetts), Theracell, Inc. is a company focused on the development of advanced technologies for bone and soft tissue repair. The company is based in Sherman Oaks, CA and maintains offices and laboratories in other locations. The company is the inventor of the next-generation, TheraFuze DBF® demineralized bone fiber technology and is also in the process of bringing its novel O2ssify oxygenation technology to market that has been demonstrated to supercharge bone formation. The company was founded in 2008 by Bradley E. Patt, who has been the CEO since then. Theracell was acquired by Isto Biologics (Massachusetts) on April 05, 2022. | Chief Executive Officer | 2007-12-31 |
HyVIDA Brands, Inc.
HyVIDA Brands, Inc. Beverages: Non-AlcoholicConsumer Non-Durables HyVIDA Brands, Inc. produces and retails hydrogen infused water beverages through online. The company was founded by Bradley Patt, Hiroyuki Funamoto and Chin-Tu Chen in 2013 and is headquartered in Northridge, CA. | Founder | 2012-12-31 |
Tetrous, Inc.
Tetrous, Inc. BiotechnologyHealth Technology Tetrous, Inc. is a regenerative medicine company that specializes in utilizing advanced technologies for enthesis repair in sports medicine applications. Tetrous is headquartered in Sherman Oaks, CA, with sales offices in IL and a laboratory in Mmoth Lakes, CA. The company's first offerings in the enfix family of products are enfix rc and enfix tac for rotator cuff repair. The company's core technology has been used in nearly 150,000 surgeries in spine applications. Tetrous was founded in 2019 and is guided by a team of influential surgeons and regenerative medicine scientists, and led by experienced medical device executives. The company was founded in 2019 by Andrew J. Carter and Bradley E. Patt. Bradley E. Patt has been the CEO of the company since January 01, 2019. | Chief Executive Officer | 2018-12-31 |
Former positions of Bradley Patt
Companies | Position | End |
---|---|---|
Gamma Medica-Ideas (USA), Inc.
Gamma Medica-Ideas (USA), Inc. Medical/Nursing ServicesHealth Services Gamma Medica-Ideas (USA), Inc. develops advanced imaging technology solutions for pre-clinical and clinical settings. It offers CZT spect detector technologies, as well as multiple modality systems for drug discovery and medical research. The firm's digital gamma ray imaging technology in LumaGEM offers significant advances in resolution and contrast allowing for identification of millimeter sized breast cancers often missed by mammography. The company was founded by Bradley E. Patt and Jan S. Iwanczyk in 2000 and is headquartered in Northridge, CA. | Founder | 2013-07-29 |
Advanced Detectors, Inc. | Chief Tech/Sci/R&D Officer | 2009-08-24 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Advanced Detectors, Inc. | Commercial Services |
Theracell, Inc.
Theracell, Inc. Medical SpecialtiesHealth Technology Part of Isto Biologics (Massachusetts), Theracell, Inc. is a company focused on the development of advanced technologies for bone and soft tissue repair. The company is based in Sherman Oaks, CA and maintains offices and laboratories in other locations. The company is the inventor of the next-generation, TheraFuze DBF® demineralized bone fiber technology and is also in the process of bringing its novel O2ssify oxygenation technology to market that has been demonstrated to supercharge bone formation. The company was founded in 2008 by Bradley E. Patt, who has been the CEO since then. Theracell was acquired by Isto Biologics (Massachusetts) on April 05, 2022. | Health Technology |
Gamma Medica-Ideas (USA), Inc.
Gamma Medica-Ideas (USA), Inc. Medical/Nursing ServicesHealth Services Gamma Medica-Ideas (USA), Inc. develops advanced imaging technology solutions for pre-clinical and clinical settings. It offers CZT spect detector technologies, as well as multiple modality systems for drug discovery and medical research. The firm's digital gamma ray imaging technology in LumaGEM offers significant advances in resolution and contrast allowing for identification of millimeter sized breast cancers often missed by mammography. The company was founded by Bradley E. Patt and Jan S. Iwanczyk in 2000 and is headquartered in Northridge, CA. | Health Services |
HyVIDA Brands, Inc.
HyVIDA Brands, Inc. Beverages: Non-AlcoholicConsumer Non-Durables HyVIDA Brands, Inc. produces and retails hydrogen infused water beverages through online. The company was founded by Bradley Patt, Hiroyuki Funamoto and Chin-Tu Chen in 2013 and is headquartered in Northridge, CA. | Consumer Non-Durables |
Tetrous, Inc.
Tetrous, Inc. BiotechnologyHealth Technology Tetrous, Inc. is a regenerative medicine company that specializes in utilizing advanced technologies for enthesis repair in sports medicine applications. Tetrous is headquartered in Sherman Oaks, CA, with sales offices in IL and a laboratory in Mmoth Lakes, CA. The company's first offerings in the enfix family of products are enfix rc and enfix tac for rotator cuff repair. The company's core technology has been used in nearly 150,000 surgeries in spine applications. Tetrous was founded in 2019 and is guided by a team of influential surgeons and regenerative medicine scientists, and led by experienced medical device executives. The company was founded in 2019 by Andrew J. Carter and Bradley E. Patt. Bradley E. Patt has been the CEO of the company since January 01, 2019. | Health Technology |
- Stock Market
- Insiders
- Bradley Patt